1. Home
  2. RNST vs BLTE Comparison

RNST vs BLTE Comparison

Compare RNST & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNST
  • BLTE
  • Stock Information
  • Founded
  • RNST 1904
  • BLTE 2018
  • Country
  • RNST United States
  • BLTE United States
  • Employees
  • RNST N/A
  • BLTE N/A
  • Industry
  • RNST Major Banks
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNST Finance
  • BLTE Health Care
  • Exchange
  • RNST Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • RNST 1.8B
  • BLTE 2.1B
  • IPO Year
  • RNST N/A
  • BLTE 2022
  • Fundamental
  • Price
  • RNST $36.36
  • BLTE $63.50
  • Analyst Decision
  • RNST Buy
  • BLTE Strong Buy
  • Analyst Count
  • RNST 5
  • BLTE 4
  • Target Price
  • RNST $39.50
  • BLTE $89.00
  • AVG Volume (30 Days)
  • RNST 375.8K
  • BLTE 71.4K
  • Earning Date
  • RNST 01-21-2025
  • BLTE 11-12-2024
  • Dividend Yield
  • RNST 2.39%
  • BLTE N/A
  • EPS Growth
  • RNST 6.89
  • BLTE N/A
  • EPS
  • RNST 3.09
  • BLTE N/A
  • Revenue
  • RNST $685,874,000.00
  • BLTE N/A
  • Revenue This Year
  • RNST N/A
  • BLTE N/A
  • Revenue Next Year
  • RNST $36.82
  • BLTE N/A
  • P/E Ratio
  • RNST $11.92
  • BLTE N/A
  • Revenue Growth
  • RNST 8.24
  • BLTE N/A
  • 52 Week Low
  • RNST $27.98
  • BLTE $31.01
  • 52 Week High
  • RNST $39.47
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • RNST 49.33
  • BLTE 44.83
  • Support Level
  • RNST $36.12
  • BLTE $60.00
  • Resistance Level
  • RNST $37.72
  • BLTE $76.87
  • Average True Range (ATR)
  • RNST 0.88
  • BLTE 4.60
  • MACD
  • RNST -0.20
  • BLTE -0.74
  • Stochastic Oscillator
  • RNST 22.67
  • BLTE 26.56

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: